November 4, 2025 Renowned Pharma and Biotech Development Leader, Dr. Andreas Wallnöfer, Is Named to Optigo Biotherapeutics’ Board of Directors as the Company Advances to IND-Enabling Studies
May 6, 2025 Optigo Biotherapeutics Wins People’s Choice Award at Eyecelerator and Presents Compelling Preclinical Data on Long-Acting Intravitreal Biologics at the ARVO 2025 Conference
April 24, 2025 Optigo Biotherapeutics Announces Presentation at Eyecelerator and Preclinical Data Poster at the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting
